This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malorny, B.
Right arrow Articles by Helmuth, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malorny, B.
Right arrow Articles by Helmuth, R.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, September 1999, p. 2278-2282, Vol. 43, No. 9
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Incidence of Quinolone Resistance Over the Period 1986 to 1998 in Veterinary Salmonella Isolates from Germany

Burkhard Malorny, Andreas Schroeter, and Reiner Helmuth*

Federal Institute for Health Protection of Consumers and Veterinary Medicine, Diedersdorfer Weg 1, D-12277 Berlin, Germany

Received 19 January 1999/Returned for modification 16 March 1999/Accepted 18 June 1999

A total of 24,591 nonhuman salmonella strains isolated in Germany between 1986 and 1998 were examined for their resistance to nalidixic acid by an agar diffusion method. The rate of resistance (inhibition zone, <= 13 mm) ranged from 0.2% in 1986 to a peak of 14.8% in 1990. Between 1991 and 1998 the MICs for nalidixic acid-resistant strains ranged from more than 256 µg/ml for nalidixic acid to between 0.25 and 128 µg/ml for enrofloxacin. In the early 1990s a particularly high incidence of fluoroquinolone resistance (49.5%) was seen among isolates of Salmonella enterica serotype Typhimurium (Salmonella Typhimurium) definitive phage type 204c that mainly originated from cattle. Among isolates from poultry an increase in the incidence of nalidixic acid resistance to a peak of 14.4% was observed in 1994. This peak was due to the presence of specific resistant serotypes, mainly serotypes Hadar, Saintpaul, Paratyphi B (D-tartrate positive; formerly serotype Java) and Newport. Such strains exhibited a decreased susceptibility to enrofloxacin (MIC, 1 µg/ml). Among isolates from pigs the peak incidence of resistance was reached in 1993, with 7.5% of isolates resistant to nalidixic acid and enrofloxacin. The study demonstrates an increase in the incidence of strains that are resistant to nalidixic acid and that have decreased susceptibility to enrofloxacin after the licensing of enrofloxacin. In addition, the number of other serotypes that exhibited nalidixic acid resistance or reduced enrofloxacin susceptibility increased among the total number of isolates investigated between 1992 and 1998.


* Corresponding author. Mailing address: Bundesinstitut für gesundheitlichen Verbraucherschutz und Veterinärmedizin, Diedersdorfer Weg 1, D-12277 Berlin, Germany. Phone: (49 30) 8412 2233. Fax: (49 30) 8412 2953. E-mail: r.helmuth{at}bgvv.de.


Antimicrobial Agents and Chemotherapy, September 1999, p. 2278-2282, Vol. 43, No. 9
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Bywater, R., Deluyker, H., Deroover, E., de Jong, A., Marion, H., McConville, M., Rowan, T., Shryock, T., Shuster, D., Thomas, V., Valle, M., Walters, J. (2004). A European survey of antimicrobial susceptibility among zoonotic and commensal bacteria isolated from food-producing animals. J Antimicrob Chemother 54: 744-754 [Abstract] [Full Text]  
  • Randall, L. P., Cooles, S. W., Piddock, L. J. V., Woodward, M. J. (2004). Mutant prevention concentrations of ciprofloxacin and enrofloxacin for Salmonella enterica. J Antimicrob Chemother 54: 688-691 [Abstract] [Full Text]  
  • Krausse, R., Ullmann, U. (2003). In Vitro Activities of New Fluoroquinolones against Campylobacter jejuni and Campylobacter coli Isolates Obtained from Humans in 1980 to 1982 and 1997 to 2001. Antimicrob. Agents Chemother. 47: 2946-2950 [Abstract] [Full Text]  
  • Liebana, E., Clouting, C., Cassar, C. A., Randall, L. P., Walker, R. A., Threlfall, E. J., Clifton-Hadley, F. A., Ridley, A. M., Davies, R. H. (2002). Comparison of gyrA Mutations, Cyclohexane Resistance, and the Presence of Class I Integrons in Salmonella enterica from Farm Animals in England and Wales. J. Clin. Microbiol. 40: 1481-1486 [Abstract] [Full Text]  
  • (2002). Policy Statements Adopted by the Governing Council of the American Public Health Association, October 24, 2001. AJPH 92: 451-483 [Full Text]  
  • Geornaras, I., Hastings, J. W., von Holy, A. (2001). Genotypic Analysis of Escherichia coli Strains from Poultry Carcasses and Their Susceptibilities to Antimicrobial Agents. Appl. Environ. Microbiol. 67: 1940-1944 [Abstract] [Full Text]  
  • Walker, R. A., Saunders, N., Lawson, A. J., Lindsay, E. A., Dassama, M., Ward, L. R., Woodward, M. J., Davies, R. H., Liebana, E., Threlfall, E. J. (2001). Use of a LightCycler gyrA Mutation Assay for Rapid Identification of Mutations Conferring Decreased Susceptibility to Ciprofloxacin in Multiresistant Salmonella enterica Serotype Typhimurium DT104 Isolates. J. Clin. Microbiol. 39: 1443-1448 [Abstract] [Full Text]  
  • Cruchaga, S., Echeita, A., Aladuena, A., Garcia-Pena, J., Frias, N., Usera, M. A. (2001). Antimicrobial resistance in salmonellae from humans, food and animals in Spain in 1998. J Antimicrob Chemother 47: 315-321 [Abstract] [Full Text]  
  • Breuil, J., Brisabois, A., Casin, I., Armand-Lefevre, L., Fremy, S., Collatz, E. (2000). Antibiotic resistance in salmonellae isolated from humans and animals in France: comparative data from 1994 and 1997. J Antimicrob Chemother 46: 965-971 [Abstract] [Full Text]  
  • Threlfall, E. J. (2000). Epidemic Salmonella typhimurium DT 104--a truly international multiresistant clone. J Antimicrob Chemother 46: 7-10 [Full Text]